Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04059016 · ClinicalTrials.gov registry record
Innovatively Increasing PCP Prescribing of Buprenorphine: Measurement Based Care and Integrated Electronic Solution
A clinical trial of Opioid Abuse and Addiction, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 75
- Enrollment target
- 1
- Study location
NCT04059016: Completed study of Opioid Abuse and Addiction, sponsored by University of Texas Southwestern Medical Center.
NCT04059016 is a study of Opioid Abuse and Addiction that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 75 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04059016, a study of Opioid Abuse and Addiction, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this observational feasibility project is to assess the feasibility and acceptability of universal screening and measurement based care for opioid use disorder (OUD) utilizing a computer software program in a network of primary care clinics currently utilizing this software for screening and measurement based care (MBC) for the treatment of depression. The primary objective of this project is to evaluate the feasibility of screening and MBC for OUD in our partner primary care clinics. The secondary objective of this project is to evaluate the acceptability of universal screening and measurement based care of OUD, including the barriers and facilitators of screening for OUD and providing buprenorphine treatment in primary care, changes in provider knowledge and beliefs regarding diagnosis and treatment of OUD, and treatment program outcomes.
Primary Outcome
The number of primary care providers who complete buprenorphine waiver training divided by the divided by the number of providers who indicate a desire/willingness to be trained will be computed.
Conditions Studied
Interventions
- OTHER MBC4OUD
Study Locations (1)
Texas
- University of Texas Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2019-08-01 |
| Est. Completion | 2024-05-02 |
What the finished NCT04059016 record still lists
NCT04059016 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target.
The record links to 1 condition, with Opioid Abuse and Addiction appearing as the primary indexed condition, and to 1 intervention - of which MBC4OUD is the first listed.
NCT04059016 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04059016 about?
NCT04059016 is a clinical study titled "Innovatively Increasing PCP Prescribing of Buprenorphine: Measurement Based Care and Integrated Electronic Solution". The objective of this observational feasibility project is to assess the feasibility and acceptability of universal screening and measurement based care for opioid use disorder (OUD) utilizing a computer software program in a network of primary care clinics currently utilizing this software for scre...
What is the current status of trial NCT04059016?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2019-08-01. Estimated completion is 2024-05-02.
What conditions does trial NCT04059016 study?
This clinical trial studies the following conditions: Opioid Abuse and Addiction.
What interventions are being tested in trial NCT04059016?
The interventions under investigation include: MBC4OUD (OTHER).
Who is sponsoring clinical trial NCT04059016?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04059016 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Abuse and Addiction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI